Veracyte
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 815
- Market Cap
- -
- Introduction
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Recruiting
- Conditions
- Pulmonary Nodule, SolitaryLung Cancer
- First Posted Date
- 2024-05-23
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Veracyte, Inc.
- Target Recruit Count
- 2400
- Registration Number
- NCT06426628
- Locations
- 🇺🇸
PulmonIx, LLC, Greensboro, North Carolina, United States
🇺🇸Bruce W. Carter Miami VA Medical Center, Miami, Florida, United States
🇺🇸University of Cincinnati, Cincinnati, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath